Fortress Biotech (FBIO) FCF Margin Growth (3y) (2018 - 2025)
Powered by 
Analysis
Fortress Biotech (FBIO) FCF Margin Growth (3y) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -5,426.00 |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 9,545.00 |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 4,612.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -3,088.00 |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 14,060.00 |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 21,420.00 |
| Sep 30, 2025 | 23,309.00 |
| Jun 30, 2025 | 6,094.00 |
| Mar 31, 2025 | 5,256.00 |
| Dec 31, 2024 | 13,708.00 |
| Sep 30, 2024 | -2,250.00 |
| Jun 30, 2024 | 4,614.00 |
| Mar 31, 2024 | -296.00 |
| Dec 31, 2023 | -2,121.00 |
| Sep 30, 2023 | 19,837.00 |
| Jun 30, 2023 | 533.00 |
| Mar 31, 2023 | -17,423.00 |
| Dec 31, 2022 | -5,913.00 |
| Sep 30, 2022 | -9,619.00 |
| Jun 30, 2022 | 8,439.00 |
| Mar 31, 2022 | 19,418.00 |
| Dec 31, 2021 | 2,780.00 |
| Sep 30, 2021 | 41,477.00 |
| Jun 30, 2021 | 20,772.00 |
| Mar 31, 2021 | 29,277.00 |